We can’t show the full text here under this license.
Abstract
Tirzepatide has demonstrated significant glycemic control and weight loss.
- Obstructive sleep apnea is often linked to obesity and negatively impacts health and quality of life.
- Weight loss is a primary treatment approach for managing obstructive sleep apnea.
- Tirzepatide acts as a dual agonist for two hormones, potentially influencing metabolic processes.
- Current literature explores tirzepatide's effects on obstructive sleep apnea and its mechanism of action.
- Complications and off-label uses of tirzepatide are also discussed in the context of metabolic conditions.
Simplified